Yu-Waye Chu insider trades

Open-market stock purchases and sales by Yu-Waye Chu, Chief Medical Officer at CytomX Therapeutics, Inc, from SEC Form 4 filings since Apr 16, 2021.

Recent trades

DateStockTradeValue
Mar 17, 2026CTMX CytomX Therapeutics, IncSold$137K
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—

Companies traded

  • CTMX CytomX Therapeutics, Inc: 2 sales, last Mar 17, 2026
  • FATE Fate Therapeutics Inc: 16 sales, last Apr 18, 2023

Get free alerts when Yu-Waye Chu files a new trade →